Two early-phase clinical trials show impressive response rates and symptom improvement with the selective KIT inhibitor avapritinib, which will provide a much-needed new treatment option for patients.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Lung-specific MCEMP1 functions as an adaptor for KIT to promote SCF-mediated mast cell proliferation
Nature Communications Open Access 11 April 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Valent, P., Akin, C. & Metcalfe, D. D. Blood 129, 1420–1427 (2017).
Metcalfe, D. D. J. Invest. Dermatol. 96, 2S–4S (1991).
Castells, M. & Austen, K. F. Int. Arch. Allergy Immunol. 127, 147–152 (2002).
Theoharides, T. C., Valent, P. & Akin, C. N. Engl. J. Med. 373, 163–172 (2015).
Escribano, L., Akin, C., Castells, M., Orfao, A. & Metcalfe, D. D. Ann. Hematol. 81, 677–690 (2002).
Escribano, L. et al. J. Allergy Clin. Immunol. 124, 514–521 (2009).
Lim, K. H. et al. Blood 113, 5727–5736 (2009).
Nagata, H. et al. Proc. Natl Acad. Sci. USA 92, 10560–10564 (1995).
DeAngelo, D. J. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01538-9 (2021).
Gotlib, J. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01539-8 (2021).
Gotlib, J. et al. N. Engl. J. Med. 374, 2530–2541 (2016).
Castells, M. & Butterfield, J. J. Allergy Clin. Immunol. Pract. 7, 1097–1106 (2019).
Akin et al. J. Allergy Clin. Immunol. 145, AB336 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.C. and C.A. have consultancy agreement with and receive research funding from Blueprint Medicines.
Rights and permissions
About this article
Cite this article
Castells, M., Akin, C. Finding the right KIT inhibitor for advanced systemic mastocytosis. Nat Med 27, 2081–2082 (2021). https://doi.org/10.1038/s41591-021-01588-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01588-z
This article is cited by
-
Lung-specific MCEMP1 functions as an adaptor for KIT to promote SCF-mediated mast cell proliferation
Nature Communications (2023)